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Cranberry Chemistry for 
Plant Disease Resistance 
and Human Health 
Catherine Neto, Ph.D. 
Department of Chemistry & Biochemistry, UMass Dartmouth 
Director, UMass Cranberry Health Research Center 
A bridge between two goals 
• The chemistry of plants is related to both 
plant health and human health 
• Cranberries contain unique and diverse 
compounds produced in defense against UV 
light, fungi, predators and other stresses 
• Many of these “phenolic” defense compounds 
are antioxidants and antimicrobials that may 
also improve human health and nutrition 
 
 
Collaboration between UMD and 
Cranberry Experiment Station 
 Goal (2006-present): Study relationship 
between pest/disease resistance and plant 
chemistry 
– Insect pests 
– Pathogenic fungi 
– Use data for sustainability 
– Funded by USDA Special Grant and UMD 
Cranberry 
– Justine Vanden Heuvel, Frank Caruso, Anne 
Averill, Carolyn Demoranville, Cathy Neto 
Greenhouse Feeding Trial 
FEEDING DAMAGE ON NEW GROWTH OF HOWES AND EARLY BLACK CRANBERRY 
UPRIGHTS BY THREE INSECT PESTS 
Insect Cultivar Time No. of uprights exhibiting: Avg. 
Scorez 
p-value 
(cultivar) 
No 
feeding 
Light 
feeding 
Medium 
feeding 
Heavy 
feeding 
Gypsy 
Moth 
Howes 24 h 9 8 12 3 1.28 0.0009 
Early 
Black 
13 18 1 0 0.63 
Weevil Howes 
 
72 h 2 19 5 6 1.47 0.2353 
Early 
Black 
6 15 9 2 1.22 
Flea 
Beetle 
Howes 5 d 1 10 17 4 1.75 0.0532 
Early 
Black 
6 14 7 5 1.34 
z Uprights were scored as having no feeding (0), light feeding (1), medium feeding (2), or heavy feeding (3).  
(Vanden Heuvel, Averill and Sylvia, 2005) 
• Feeding study showed two 
cranberry pests feed more 
heavily on Howes cultivar vs. 
Early Black foliage 
 
• HPLC analysis identified 
several phenolic compounds 
present at higher levels in 
Early Black leaves 
 
• May play a role in resistance 
Gypsy Moth, 3rd instar 
(Lymantria dispar L.) 
Flea Beetle  
(Systena frontalis F.) 
Early finding: Quercetin and other phenolics 
may deter insects from feeding 
Neto, Vanden Heuvel, et al., “Variation in conc. of phenolic acid derivatives and quercetin glycosides in 
foliage of Vaccinium macrocarpon that may play a role in pest deterrence,” J. Am. Soc. Hort. Sci., 2010. 
Quercetin glycosides 
 
Objectives 2008-present 
• Collect berry and leaf samples from pest and 
disease resistant and susceptible cranberry 
cultivars 
 
• Prepare and analyze extracts from different bogs, 
seasons and growing regions 
 
• Compare their chemical compositions 
 
• Identify compounds that may play a role in 
resistance or serve as markers 
 
• Develop new analysis methods 
Casting a wider net 
• 2008-09 samples collected in MA (F. Caruso) 
– Howes, Early Black, Ben Lear, Bugle 
• Broader range of samples collected 2010-11 
• Includes newer cultivars:  
– Crimson Queen, Demoranville, Mullica Queen 
• MA, NJ, Wisconsin, British Columbia (N. 
Vorsa) 
• Analysis for phenolic composition and 
proanthocyanidin (PAC) content 
 
 
1. How do “pest-resistant” phenolics 
vary with cultivar, bog, stress? 
• Leaves were collected in June 2009 & 
2010 from 14 sites in MA (F. Caruso) 
• Healthy and stressed plants (Phytophthera 
root rot, tipworm) 
• Extracts were prepared and analyzed by 
HPLC for content of quercetin and 
coumaric acid derivatives (Eleni Yiantsidis, 
Anthony Dovell) 
Production of quercetin compounds in 
Early Black varies between bogs 
* 
* 
* 
* 
State Bog was  
highest 
Production of several metabolites was 
decreased in stressed Ben Lear plants 
Stressed plants had 
lower coumaroyl content 
2. Resistance to fungal pathogens  
• Cultivars vary in resistance to fruit rot and 
other diseases caused by fungi 
• Bugle > Early Black > Ben Lear  
• Which compounds play a role? How do they 
affect fungi?  (F. Caruso, M. Nunnelley) 
 
• Fruit and leaf samples collected, extracted 
and analyzed by HPLC in 2008-09 
• Tested for effect on growth of several fungi 
using disc-diffusion assays 
Cranberry plant pathogens of concern in 
Southeastern MA 
Fruit rot:  
• Fusicoccum putrifaciens 
• Coleophoma emptetri 
• Phomopsis vaccinii 
• Physalospora vaccinii 
• Colletotrichum acutatum 
  
Leaf spot (young beds) 
•  Colletotrichum acutatum 
•  Phyllosticta vaccinii 
 
Root rot 
Phytophthera spp. 
 
 
General trend in resistance by cranberry cultivar: 
 
Bugle > Early Black > > Ben Lear > HyRed 
Fungi treated with cranberry 
extracts showed a stress response 
• Extracts of berries 
and leaves 
containing PACs 
(proanthocyanidins) 
caused melanin 
production 
• PACs may play a 
defense role 
against fungi 
Berry PACs 
Berry crude Leaf crude 
Leaf PACs 
Phomopsis 
vaccinii cultures  
3. How does PAC content vary between 
cultivars, seasons, regions? 
• PACs may be vital both to human health 
(UTI protection) and plant health  
• Scant data on PAC content by cultivar  
• Fruit samples collected in 2009 and 2010 
(F. Caruso, N. Vorsa)  
• Fruit extracts were analyzed for PAC 
content using DMAC assay (J. Carpenter) 
 
Average PAC content in 2010 MA fruit samples by cultivar 
(5 cultivars, 1-3 bogs) 
PAC Concentration of Massachusetts Cultivar Averages for 2010 DMAC Results
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•  Howes variety was significantly higher in PACs than     
   all other cultivars (except Early Black) 
•  Ben Lear was significantly lower in PACs than the  
   others (p < 0.001) 
Average PAC content in 2010 fruit samples from MA bogs (DMAC) 
PAC content in 2010 samples by growing region 
PAC Concentrations from 2010 New Jersey Cranberry Samples from DMAC 
Cranberry Sample
MQ-NJ Dem-NJ S-NJ CQ-NJ US88-1 US94-181 US88-70
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PAC Concentrations from Wisconsin 2010 Cranberry Samples from DMAC
Cranberry Sample
S-WI BL-WI CQ-WI Dem-WI
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PAC Concentration of British Columbia 2010 Cranberry Samples from DMAC
Cranberry Sample
MQ-BC BL-BC Dem-BC S-BC CQ-BC
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Stevens, Crimson Queen 
did not differ significantly 
by region in 2010 
• Mullica Queen did: 
 BC > MA ≈ NJ 
 
 
2010 New Jersey 2010 Wisconsin 
2010 British Columbia 
Seasonal difference in PACs: 2009 vs. 2010 
PAC Concentrations of 2009 vs. 2010 Cranberries
Cranberry Samples
2009 Samples 2010 Samples
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Early Black
Bugle Card
Howes Sandusky
Ben Lear Eagleholt
2010 was a harsher 
growing season with a 
high incidence of fruit rot 
PAC Content in samples from selected MA bogs 
2009 vs. 2010 
PAC content in EB, Ben 
Lear and Bugle fruit 
was significantly lower 
in 2010 (p < 0.05) 
 
 
2011 samples TBA 
 
NMR analysis of plant extracts 
“metabolomics” 
• Fast, efficient 
• Gives a snapshot of chemical composition 
• Can be used to verify botanical species, 
origin, where a plant is grown 
• Can detect samples that differ in 
composition, identify and quantify key 
compounds 
• Bruker and UMD are developing it as a 
tool for cranberry sample analysis  
NMR data shows 
differences between 
foliage of Vaccinium 
species that can be 
used to validate 
samples 
Separation of samples in 
clusters indicates differences in 
chemical composition V. corymbosum 
V. uliginosum 
V. angustifolium 
V. macrocarpon 
MA vs. Ottawa 
Variation in cranberry leaf samples  
Healthy vs. diseased plants 
(Phytophthera) 
Clustering of data points shows 
that cultivars differ in composition 
         SHAWC-16  Ben Lear with root rot 
    SHAWC-16   Ben Lear Healthy 
      Ben Lear 
      Bugle 
      Early Black 
      Howes 
      Wild Vines 
Determination of PACs by NMR 
• Bruker – UMD collaboration (K. Colson, B. 
Pereira) 
• 1H NMR analysis of cranberry extracts can 
detect A-type PACs 
• Signal intensity is proportional to content 
• Developing NMR method to quantify      
A-type PACs in cranberry samples 
Summary 
• Quercetin, phenolics and PACs play both 
plant defense and human health roles 
• Composition varies in response to stress, 
location, season 
• Analysis of 2011 samples will better define 
regional, cultivar, and seasonal differences 
• Further characterization of key compounds 
• Development of NMR method for PACs 
• How can we use this information to help 
cranberry industry?  
 
UMass Cranberry Health 
Research Center 
http://www.umassd.edu/chrc/ 
Funded by a $110 K grant from the UMass 
President’s Science and Technology Fund 
Directors:  Cathy Neto and Maolin Guo (UMD) 
Cranberries and Human Health 
• Cranberries are best known for 
protection against UTI 
• Contain health-promoting 
antioxidants like those in red 
wine and blueberries 
• We identified berry compounds 
that reduce cancer cell growth, 
oxidative stress, microbes 
• Possible protection against colon 
cancer, heart disease, diabetes, 
Alzheimer’s, infections? 
 
Goal: Establish the science behind 
health benefits 
• How do these compounds work? 
• Are they bioavailable in animals? Humans? 
• What are the metabolites? 
• How can we measure efficacy? 
• What other diseases or conditions might 
cranberry protect against? 
• Which varieties, products, formulations are 
the healthiest? 
Goals of CHRC Project 
• Establish a collaborative center for cranberry-
health research across five UMass campuses 
• Bring together researchers with common 
interests to work together 
• Pursue federal grant funding (NIH, USDA, 
NSF), industry & state sources 
• Focus areas year one:  
– Colon cancer  
– Oxidative stress 
• Future: identify & develop other priority areas 
Activities 
• CHRC website on the UMD site 
• Two $25 K seed grants to be awarded – RFP 
posted in January, proposals due in March 
• Next: press release, publicize center to 
industry, seek new funding sources 
• Collaborators meet for proposal development 
• Cranberry Health Research Symposium (Fall 
2012) 
• Goals: NIH R01 proposals, identify additional 
funding to sustain center 
CHRC Website: 
http://www.umassd.edu/chrc/  
UMass CHRC participants 
Cathy Neto, Director 
Chemistry, cancer Maolin Guo, Director, 
Biochemistry, imaging 
Tracie Ferreira, PhD 
Molecular Biology 
UMD Bioengineering 
Frank Scarano, PhD 
Microbiology 
UMD Med Lab Sci 
Carolyn Demoranville 
UMass Cranberry Station 
CHRC Advisory Board 
John Sullivan, MD 
VP for Research, UMMS 
CHRC Advisory Board 
Hang Xiao, PhD 
Cancer, metabolism 
UMA Food Science 
John Keaney, MD 
Chief of Cardiology  
UMMS 
Eric Decker, Chair 
UMA Food Science 
Advisory Board 
Neto Research Group 
• >10 years’ expertise in cranberry phytochemical 
separation, analysis and health research, funded 
by state, federal, private grants 
• Collaborators at UPEI, WPI & Cornell 
• Our studies show cranberry compounds inhibit 
development of colon, prostate & breast cancer 
• Antimicrobial research  with oral bacteria, yeasts 
(Candida), E. coli, plant pathogens  
• Anticancer and antioxidant studies, cellular protein 
and gene expression 
• Teaming up with scientists using animal/clinical 
models is critical to furthering this research 
 
Guo Research Group 
• Biochemistry of iron and other metals, role 
of iron in biological processes and 
diseases, interactions with cranberry  
• Molecular biology and protein biochemistry 
• Live cell imaging methods , fluorescent 
tagging of molecules 
• Sensor and probe development 
• Bioassays – antibacterial, antioxidant, 
enzyme-based assays, spectroscopy 
 
 UMass CHRC helps support student research 
Academic-Industry partnership  
Advisory Board Members (industry): 
• Cranberry Institute - Martin Starr 
• Ocean Spray Inc. - Christina Khoo 
• Decas Cranberries Inc. - Reza Ghaedian  
• Cranberry Marketing Committee - TBA 
• Brunswick Laboratories Inc. - Boxin Ou, Vice President 
• Microbiotics Inc. - Terry Bowlin, President/CEO 
 
Advisory Board Members (academic): 
• UMass Medical School/CCTS -  John Sullivan, Nate Hafer 
• UMass Cranberry Station – Carolyn Demoranville 
• UMass Amherst Food Science – Eric Decker 
• Harvard Medical/MacLean Hospital – David Lee 
Sustainability of CHRC? 
• Federal grant funding levels are very low 
• S & T grant provides only for Year 1 
• Challenge:  convince industry and state to 
invest in CHRC 
• We need to provide continued support for 
students, new research projects  
• We welcome your input and suggestions!  
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Cranberries: 
 
Better health for the 
Commonwealth 
 
http://heartcurrents.files.wordpress.com/2010 
Cranberry 
Health      
Research  
Center 
